Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMJGleeson Regulatory News (GLE)

Share Price Information for MJGleeson (GLE)

Share Price is delayed by 15 minutes
Get Live Data
248.50    3.50 (1.43%)
Bid:
249.00
Ask:
251.00
Spread: 2.00 (0.803%)
Market Cap: £144.97m
GLE Live PriceLast checked at - London Stock Exchange

Intraday MJGleeson Share Chart

Trading Update

15 May 2015 07:00

RNS Number : 2445N
MJ Gleeson PLC
15 May 2015
 

Gleeson (MJ) plc

 

Trading update

 

Gleeson (GLE.L), the urban regeneration and strategic land specialist, is pleased to provide a trading update for the period from 1 January 2015 to 30 April 2015.

 

Gleeson has two divisions:

 

· Gleeson Homes An urban regeneration specialist in the North of England, with a particular focus on low cost family homes

 

· Gleeson Strategic Land A strategic land promotion business, mainly in the South of England, that enhances the value of land through the planning process and sells it to developers

 

Gleeson Homes

 

Gleeson Homes has continued to perform well and total sales for the year to date, comprising reserved, contracted and completed homes are up by 12% on last year. The business now expects to record at least 730 completions in the year to 30 June 2015, a 30% increase on the 561 units completed in the prior year. In addition, the Group will once again enter the next financial year with a strong forward order book. 

 

The Government's "Help to Buy" initiative continues to be a popular, with 42% of our purchasers in the year to date taking advantage of the scheme.

 

Gleeson Homes currently has 41 active sites, compared with 37 at the same stage last year, with a total of 5,801 plots either owned or conditionally purchased.

 

The business is in active discussions regarding the acquisition of a further 13 sites which, if purchased, will add 1,855 plots to the regeneration land pipeline, taking the total number of plots to in excess of 7,750.

 

Gleeson Strategic Land

 

Gleeson Strategic Land has to date performed in line with the Board's expectations, enhancing its portfolio and progressing sites through the planning system. In line with increasing activity in the housing market, there has been a further improvement in the prices that volume housebuilders are willing to pay for green field residential land in the South of England.

 

During the period we sold a 28 acre site with planning permission for 180 units.

 

The strategic portfolio consists of 68 sites totalling 3,887 gross acres, which have the potential to deliver 20,900 plots. Of these, 13 sites currently either have submitted planning applications, or planning appeals lodged, and together have the potential to deliver 100 acres of commercial land, a 60 bed nursing home and in excess of 2,150 plots.

 

Additionally, 12 of the sites have planning permission or a resolution to grant permission. Although the exact timing of land sales is always difficult to predict, the Board is hopeful that a significant number of these sites will be sold either beforethe end of the current financial year or early in the following year.

 

Outlook

 

The Board is encouraged by the performance of both Gleeson Homes and Gleeson Strategic Land in the period under review and remains confident that there will be further substantial improvements in the Group's trading performance in both the current year and beyond.

 

The Group's underlying profit for the full year, excluding the write down in investments and the cost of the restructuring successfully completed in December 2014, is expected to be in line with current expectations and could exceed expectations, subject to the timing of any additional Strategic Land sales.

 

 

 

15 May 2015

Enquiries:

MJ Gleeson plc

 

Tel: +44 1252 360 300

Jolyon Harrison

Chief Executive Officer

 

Alan Martin

Chief Financial Officer

 

 

 

 

Instinctif

 

Tel: +44 20 7457 2020

Mark Garraway

 

 

Helen Tarbet

 

 

James Gray

 

 

 

 

 

N+1 Singer

 

 

Shaun Dobson

 

Tel: +44 20 7496 3000

Alex Laughton-Scott

 

 

Ben Griffiths

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTGGUBWAUPAGAC
Date   Source Headline
30th Nov 20237:00 amRNSTotal Voting Rights
27th Nov 20234:29 pmRNSDirector/PDMR Shareholding
16th Nov 20231:33 pmRNSResult of AGM
16th Nov 20237:00 amRNSAGM Trading Update
8th Nov 20233:29 pmRNSDirector/PDMR Shareholding
31st Oct 20237:00 amRNSTotal Voting Rights
24th Oct 20234:17 pmRNSDirector/PDMR Shareholding
23rd Oct 20231:56 pmRNSExercise of Options & Director/ PDMR Dealing
17th Oct 20237:00 amRNSNotice of AGM
6th Oct 20232:37 pmRNSDirector/PDMR Shareholding
29th Sep 20237:00 amRNSTotal Voting Rights
27th Sep 20234:17 pmRNSExercise of Options & PDMR Dealing
26th Sep 20234:38 pmRNSDirector/PDMR Shareholding
15th Sep 20233:54 pmRNSDirector/PDMR Shareholding
15th Sep 202310:35 amRNSDirector/PDMR Shareholding
14th Sep 20234:41 pmRNSDirector/PDMR Shareholding
14th Sep 20237:00 amRNSAudited results for the year ended 30 June 2023
7th Sep 202312:20 pmRNSDirector/PDMR Shareholding
31st Aug 20237:00 amRNSTotal Voting Rights
8th Aug 20234:55 pmRNSDirector/PDMR Shareholding
31st Jul 20237:00 amRNSTotal Voting Rights
7th Jul 20233:48 pmRNSDirector/PDMR Shareholding
7th Jul 20237:00 amRNSTrading Update and Capital Markets Day
30th Jun 20237:00 amRNSSale of portfolio of homes to Carlyle
30th Jun 20237:00 amRNSTotal Voting Rights
8th Jun 20232:23 pmRNSDirector/PDMR Shareholding
31st May 20237:00 amRNSTotal Voting Rights
15th May 20233:30 pmRNSHolding(s) in Company
10th May 20231:56 pmRNSDirector/PDMR Shareholding
28th Apr 20237:00 amRNSTotal Voting Rights
14th Apr 202310:01 amRNSDirector/PDMR Shareholding
6th Apr 202311:13 amRNSDirector/PDMR Shareholding
5th Apr 20234:37 pmRNSDirector/PDMR Shareholding
31st Mar 20237:00 amRNSTotal Voting Rights
29th Mar 20237:00 amRNSDirector/PDMR Shareholding
24th Mar 20237:00 amRNSRe Directorate
21st Mar 20237:00 amRNSNotice of Capital Markets Day and Trading Update
13th Mar 20233:58 pmRNSSigning of the Self-Remediation Terms
8th Mar 20235:13 pmRNSDirector/PDMR Shareholding
28th Feb 20237:00 amRNSTotal Voting Rights
27th Feb 202312:05 pmRNSPerformance Share Plan award to Directors & PDMRs
16th Feb 20237:00 amRNSResults for the half-year ended 31 December 2022
8th Feb 20235:18 pmRNSCommittee appointments
8th Feb 20231:45 pmRNSDirector/PDMR Shareholding
31st Jan 20237:00 amRNSTotal Voting Rights
13th Jan 20237:00 amRNSTrading Update & Notice of Results
6th Jan 20234:42 pmRNSDirector/PDMR Shareholding
3rd Jan 20237:00 amRNSRe Directorate
30th Dec 20227:00 amRNSTotal Voting Rights
15th Dec 202211:06 amRNSDirectorate External Appointments

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.